The Medicare Part D program could have saved $3 billion in 2016
According to new data from Health and Human Services (HHS), using generic drugs instead of their brand-name equivalents could have
Read More
Health Care Finance
New report suggests rebates are not to blame for increasing drug prices
A new report by the consulting company Milliman prepared for America’s Health Insurance Plans (AHIP), suggest that drug rebates are
Read MoreCongress considers 340B changes
(By Emily Rappleye for Becker’s Hospital Review) The House reviewed 15 bills July 11 that would revamp the oversight, transparency and organization
Read MoreMedicare patients pay less for drugs if they pay cash
A recent U.S. study suggests that Medicare patients pay less when they pay cash instead of using their health insurance.
Read MoreCan A Community Hospital Stay True To Its Mission After Sale To Large Corporation?
(By Steven Findlay for Kaiser Health News) Mission Health, the largest hospital system in western North Carolina, provided $100 million
Read MoreTrump considers drug rebate shake-up: 5 things to know
(By Alia Paavola for Becker’s Hospital Review) The Trump administration is considering a proposal that will remove or alter safe
Read MoreMerck joins the list of drug makers agreeing to freeze or lower some prices
(By Ed Silverman for STAT) As political pressure on the pharmaceutical industry builds, Merck has become the latest big drug
Read MoreNew proposal would remove safe-harbor protections for drug rebates
The Office of Management and Budget was sent a proposed regulation that would make changes to federal safe harbor protections
Read MoreMedicare’s bundled-payment system did not reduce costs
In a new study led by Washington University School of Medicine in St. Louis found Medicare’s bundled-payment system did not
Read MoreFDA’s Gottlieb slams drug makers for stalling release of biosimilars
(By Erin Mershon for STAT) WASHINGTON — Food and Drug Administration Commissioner Scott Gottlieb on Wednesday accused drug makers who
Read More